Suresh Pai.jpg

Suresh Pai

Suresh Pai has over 25 years of commercial development and general management experience in a wide variety of medical device segments spanning plastic surgery implantables (Mentor/J&J), vascular stents (Cordis/J&J and SquareOne), stent-grafts for thoracic aortic aneurysms (ProGraft Medical/W.L. Gore), devices for crossing chronic total vascular occlusions (LuMend/J&J), carotid artery stents and embolic filters (Boston Scientific), and femoral closure device technologies (AccessClosure/Cardinal Health). He co-founded Axiom Technology Partners, a startup that developed a novel laparoscopic fascial closure device, which was acquired in 2012 by Teleflex Medical (NYSE: TFX). Axiom’s device was awarded Innovation of the Year by Society of Laparoscopic Surgeons, as well as the Excellence in Surgical Products Award by Surgical Products Magazine, both in 2012. Most recently, Suresh was the founder of the ear, nose and throat device startup CogENT Therapeutics (a Band of Angels portfolio company), which developed and commercialized a unique hemostatic nasal packing technology which was acquired by Entellus Medical (NASDAQ: ENTL) in mid-2016. Currently, Suresh is Managing Partner at LamaMed Solutions, Inc., a Silicon Valley based medical device consultancy focused on startups. He has received over fifty US and international patents covering a variety of technologies in the medical device field. Suresh holds a MS in biomedical engineering from the University of Miami and a BS in biomedical engineering from Tulane University.